Tailored antiplatelet therapy in a patient with ITP and clopidogrel resistance

Thromb Haemost. 2015 Mar;113(3):664-7. doi: 10.1160/TH14-09-0751. Epub 2014 Nov 27.

Authors

Grazia Loredana Mendolicchio¹, Dennis Zavalloni, Monica Bacci, Matteo Roveda, Vittorio Quagliuolo, Chiara Viviani Anselmi, Lidia L Rota, Zaverio M Ruggeri

Affiliation

¹ Grazia Loredana Mendolicchio, MD, PhD, Laboratori di Ricerca Emostasi e Trombosi, Humanitas Clinical and Research Center, via Manzoni 56, 20089 Rozzano (Milano), Italy, Tel.: +39 02 8224 4630, Fax: +39 02 8224 4691, E-mail: loredana.mendolicchio@humanitas.it.

PMID: 25428265
DOI: 10.1160/TH14-09-0751

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adenosine / analogs & derivatives*
Adenosine / therapeutic use
Clopidogrel
Coronary Thrombosis / etiology
Coronary Thrombosis / prevention & control*
Drug Resistance*
Drug Substitution*
Humans
Male
Middle Aged
Myocardial Infarction / complications
Myocardial Infarction / diagnosis
Myocardial Infarction / therapy*
Percutaneous Coronary Intervention* / adverse effects
Platelet Aggregation Inhibitors / therapeutic use*
Platelet Function Tests
Predictive Value of Tests
Purpura, Thrombocytopenic, Idiopathic / blood
Purpura, Thrombocytopenic, Idiopathic / complications*
Purpura, Thrombocytopenic, Idiopathic / diagnosis
Purpura, Thrombocytopenic, Idiopathic / drug therapy
Ticagrelor
Ticlopidine / analogs & derivatives*
Ticlopidine / therapeutic use
Time Factors
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Clopidogrel
Ticagrelor
Adenosine
Ticlopidine